ConductScience.org, home

Paper42453508

Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.

Zhang Z and 9 others. Front Endocrinol (Lausanne), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study. Papers, record 42453508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42453508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.
PubMed
Journal
Front Endocrinol (Lausanne)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Validation Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang ZZhanLin
2Ma GGuoXia
3Ma MMeiFang
4Guo TTianRong
5Zhao YYu
6Cheng XXiuSheng
7Yan ZZhonglin
8Yin ZZhengMing
9Wang GGangyi
10An YYongDong

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Diabetic NephropathiesMajor topic
NomogramsMajor topic
Humans
Female
Retrospective Studies
Risk Factors
Middle Aged
Male
Prediction Algorithms
ROC Curve
Aged
Risk Assessment

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14141213511th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050.Lancet Diabetes Endocrinol2026https://conductscience.org/library/papers/41412135PubMed
239806549Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study.Diabetes Obes Metab2025https://conductscience.org/library/papers/39806549PubMed
332095345Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy.PeerJ2020https://conductscience.org/library/papers/32095345PubMed
438746045Machine Learning-Based Predictive Modeling of Diabetic Nephropathy in Type 2 Diabetes Using Integrated Biomarkers: A Single-Center Retrospective Study.Diabetes Metab Syndr Obes2024https://conductscience.org/library/papers/38746045PubMed
541585789Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41585789PubMed
639337706Novel Insights into Diabetic Kidney Disease.Int J Mol Sci2024https://conductscience.org/library/papers/39337706PubMed
736523225External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study.BMJ Open2022https://conductscience.org/library/papers/36523225PubMed
836890275Effects of Uric Acid-Lowering Therapy on the Kidney (HTR-2023-0096.R2).Hypertens Res2023https://conductscience.org/library/papers/36890275PubMed
934962526Prevalence and Treatment of Diabetes in China, 2013-2018.JAMA2021https://conductscience.org/library/papers/34962526PubMed
1039579774Diabetes in China part 1: epidemiology and risk factors.Lancet Public Health2024https://conductscience.org/library/papers/39579774PubMed
1134642880Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis.Clin Rheumatol2022https://conductscience.org/library/papers/34642880PubMed
1236384320Regularization approaches in clinical biostatistics: A review of methods and their applications.Stat Methods Med Res2023https://conductscience.org/library/papers/36384320PubMed
1338374967Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.EClinicalMedicine2024https://conductscience.org/library/papers/38374967PubMed
1430927104Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome.Acta Diabetol2019https://conductscience.org/library/papers/30927104PubMed
1540012233Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study.Ren Fail2025https://conductscience.org/library/papers/40012233PubMed
1640600445Multi-modal models using fMRI, urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease.Diabetes Obes Metab2025https://conductscience.org/library/papers/40600445PubMed
1741669246A meta-analysis of serum uric acid and diabetic nephropathy risk in type 2 diabetes.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41669246PubMed
1841685239Machine learning model based on routine blood and biochemical parameters for early diagnosis of diabetic kidney disease.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41685239PubMed
1935864124A simplified prediction model for end-stage kidney disease in patients with diabetes.Sci Rep2022https://conductscience.org/library/papers/35864124PubMed
2038230268A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.J Hepatocell Carcinoma2024https://conductscience.org/library/papers/38230268PubMed

See all 43 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42453508

GET https://conductscience.org/api/papers/v1/42453508/references?page=2